nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—CYP1A1—Methoxsalen—vitiligo	0.455	0.595	CbGbCtD
Erlotinib—CYP1A2—Methoxsalen—vitiligo	0.203	0.266	CbGbCtD
Erlotinib—CYP3A4—Methoxsalen—vitiligo	0.107	0.139	CbGbCtD
Erlotinib—Dermatitis acneiform—Methoxsalen—vitiligo	0.0186	0.17	CcSEcCtD
Erlotinib—Skin hyperpigmentation—Methoxsalen—vitiligo	0.0107	0.0975	CcSEcCtD
Erlotinib—Folliculitis—Methoxsalen—vitiligo	0.0101	0.0923	CcSEcCtD
Erlotinib—Blister—Methoxsalen—vitiligo	0.00882	0.0804	CcSEcCtD
Erlotinib—MKNK1—hair follicle—vitiligo	0.00786	0.133	CbGeAlD
Erlotinib—Tenderness—Methoxsalen—vitiligo	0.00728	0.0665	CcSEcCtD
Erlotinib—Inflammation—Methoxsalen—vitiligo	0.00655	0.0598	CcSEcCtD
Erlotinib—Skin exfoliation—Methoxsalen—vitiligo	0.00607	0.0554	CcSEcCtD
Erlotinib—Dermatitis bullous—Methoxsalen—vitiligo	0.00483	0.044	CcSEcCtD
Erlotinib—SLK—Caspase Cascade in Apoptosis—GZMB—vitiligo	0.00444	0.067	CbGpPWpGaD
Erlotinib—AURKC—thyroid gland—vitiligo	0.00423	0.0716	CbGeAlD
Erlotinib—Dry skin—Methoxsalen—vitiligo	0.00423	0.0386	CcSEcCtD
Erlotinib—SLK—Caspase Cascade in Apoptosis—CASP7—vitiligo	0.00406	0.0614	CbGpPWpGaD
Erlotinib—JAK3—thyroid gland—vitiligo	0.00392	0.0664	CbGeAlD
Erlotinib—CYP1B1—hair follicle—vitiligo	0.00378	0.0639	CbGeAlD
Erlotinib—CYP1A1—skin epidermis—vitiligo	0.00374	0.0633	CbGeAlD
Erlotinib—TNK1—thyroid gland—vitiligo	0.0036	0.0609	CbGeAlD
Erlotinib—Depression—Methoxsalen—vitiligo	0.00355	0.0323	CcSEcCtD
Erlotinib—MKNK1—Signaling mediated by p38-alpha and p38-beta—MITF—vitiligo	0.00322	0.0486	CbGpPWpGaD
Erlotinib—ABL2—thyroid gland—vitiligo	0.00295	0.05	CbGeAlD
Erlotinib—EGFR—thyroid gland—vitiligo	0.00288	0.0488	CbGeAlD
Erlotinib—Arrhythmia—Methoxsalen—vitiligo	0.00285	0.026	CcSEcCtD
Erlotinib—PIP4K2C—thyroid gland—vitiligo	0.00279	0.0473	CbGeAlD
Erlotinib—Erythema—Methoxsalen—vitiligo	0.00278	0.0253	CcSEcCtD
Erlotinib—ULK3—thyroid gland—vitiligo	0.00267	0.0451	CbGeAlD
Erlotinib—MKNK1—thyroid gland—vitiligo	0.00251	0.0425	CbGeAlD
Erlotinib—EGFR—Stabilization and expansion of the E-cadherin adherens junction—LPP—vitiligo	0.00248	0.0375	CbGpPWpGaD
Erlotinib—SLK—thyroid gland—vitiligo	0.00238	0.0402	CbGeAlD
Erlotinib—Oedema—Methoxsalen—vitiligo	0.00227	0.0207	CcSEcCtD
Erlotinib—Infection—Methoxsalen—vitiligo	0.00225	0.0206	CcSEcCtD
Erlotinib—Skin disorder—Methoxsalen—vitiligo	0.0022	0.0201	CcSEcCtD
Erlotinib—ABL1—PDGFR-beta signaling pathway—SLA—vitiligo	0.00211	0.0319	CbGpPWpGaD
Erlotinib—STK10—thyroid gland—vitiligo	0.00207	0.035	CbGeAlD
Erlotinib—Insomnia—Methoxsalen—vitiligo	0.00205	0.0187	CcSEcCtD
Erlotinib—Dyspepsia—Methoxsalen—vitiligo	0.002	0.0182	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Methoxsalen—vitiligo	0.00196	0.0179	CcSEcCtD
Erlotinib—ABL1—skin of body—vitiligo	0.00194	0.0328	CbGeAlD
Erlotinib—MAP2K5—thyroid gland—vitiligo	0.00185	0.0312	CbGeAlD
Erlotinib—Body temperature increased—Methoxsalen—vitiligo	0.00179	0.0164	CcSEcCtD
Erlotinib—CYP1B1—skin of body—vitiligo	0.00164	0.0278	CbGeAlD
Erlotinib—Pruritus—Methoxsalen—vitiligo	0.0016	0.0146	CcSEcCtD
Erlotinib—JAK3—IL-7 Signaling Pathway—IL2RA—vitiligo	0.00157	0.0237	CbGpPWpGaD
Erlotinib—Dizziness—Methoxsalen—vitiligo	0.0015	0.0137	CcSEcCtD
Erlotinib—SLCO2B1—thyroid gland—vitiligo	0.00144	0.0243	CbGeAlD
Erlotinib—JAK3—Interleukin receptor SHC signaling—IL2RA—vitiligo	0.00143	0.0217	CbGpPWpGaD
Erlotinib—Rash—Methoxsalen—vitiligo	0.00143	0.013	CcSEcCtD
Erlotinib—Dermatitis—Methoxsalen—vitiligo	0.00143	0.013	CcSEcCtD
Erlotinib—ABL1—thyroid gland—vitiligo	0.00142	0.0241	CbGeAlD
Erlotinib—Headache—Methoxsalen—vitiligo	0.00142	0.013	CcSEcCtD
Erlotinib—JAK3—IL2 signaling events mediated by STAT5—IL2RA—vitiligo	0.00136	0.0205	CbGpPWpGaD
Erlotinib—Nausea—Methoxsalen—vitiligo	0.00135	0.0123	CcSEcCtD
Erlotinib—EGFR—Direct p53 effectors—TYRP1—vitiligo	0.00125	0.0189	CbGpPWpGaD
Erlotinib—CYP1B1—thyroid gland—vitiligo	0.00121	0.0204	CbGeAlD
Erlotinib—JAK3—Oncostatin M Signaling Pathway—CASP7—vitiligo	0.0012	0.0181	CbGpPWpGaD
Erlotinib—CYP1A1—skin of body—vitiligo	0.00116	0.0196	CbGeAlD
Erlotinib—JAK3—IL2 signaling events mediated by PI3K—IL2RA—vitiligo	0.00115	0.0173	CbGpPWpGaD
Erlotinib—UGT1A1—Estrogen metabolism—GSTM1—vitiligo	0.0011	0.0167	CbGpPWpGaD
Erlotinib—JAK3—IL-2 Signaling Pathway—IL2RA—vitiligo	0.00104	0.0157	CbGpPWpGaD
Erlotinib—CYP1B1—Estrogen metabolism—GSTM1—vitiligo	0.00103	0.0155	CbGpPWpGaD
Erlotinib—JAK3—Interleukin-3, 5 and GM-CSF signaling—IL2RA—vitiligo	0.000999	0.0151	CbGpPWpGaD
Erlotinib—JAK3—Interleukin-2 signaling—IL2RA—vitiligo	0.000948	0.0143	CbGpPWpGaD
Erlotinib—JAK3—G beta:gamma signalling through PI3Kgamma—IL2RA—vitiligo	0.000932	0.0141	CbGpPWpGaD
Erlotinib—JAK3—GPVI-mediated activation cascade—IL2RA—vitiligo	0.000917	0.0138	CbGpPWpGaD
Erlotinib—ABCG2—thyroid gland—vitiligo	0.000898	0.0152	CbGeAlD
Erlotinib—JAK3—G-protein beta:gamma signalling—IL2RA—vitiligo	0.000888	0.0134	CbGpPWpGaD
Erlotinib—CYP1A2—thyroid gland—vitiligo	0.000865	0.0146	CbGeAlD
Erlotinib—CYP1A2—Aflatoxin B1 metabolism—GSTM1—vitiligo	0.00086	0.013	CbGpPWpGaD
Erlotinib—CYP1A1—thyroid gland—vitiligo	0.000853	0.0144	CbGeAlD
Erlotinib—JAK3—IL2-mediated signaling events—IL2RA—vitiligo	0.000848	0.0128	CbGpPWpGaD
Erlotinib—JAK3—SHP2 signaling—IL2RA—vitiligo	0.000801	0.0121	CbGpPWpGaD
Erlotinib—ABL1—Regulation of retinoblastoma protein—MITF—vitiligo	0.000749	0.0113	CbGpPWpGaD
Erlotinib—MKNK1—MAPK Signaling Pathway—CASP7—vitiligo	0.000745	0.0112	CbGpPWpGaD
Erlotinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—CASP7—vitiligo	0.000724	0.0109	CbGpPWpGaD
Erlotinib—EGFR—a6b1 and a6b4 Integrin signaling—CASP7—vitiligo	0.000705	0.0106	CbGpPWpGaD
Erlotinib—CYP3A4—Aflatoxin B1 metabolism—GSTM1—vitiligo	0.000664	0.01	CbGpPWpGaD
Erlotinib—CYP1A1—Estrogen metabolism—GSTM1—vitiligo	0.000634	0.00957	CbGpPWpGaD
Erlotinib—CYP1B1—Tryptophan metabolism—CAT—vitiligo	0.000514	0.00776	CbGpPWpGaD
Erlotinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—CASP7—vitiligo	0.000513	0.00774	CbGpPWpGaD
Erlotinib—JAK3—Signaling by Interleukins—IL2RA—vitiligo	0.000487	0.00736	CbGpPWpGaD
Erlotinib—UGT1A1—Phase II conjugation—GSTT1—vitiligo	0.000487	0.00735	CbGpPWpGaD
Erlotinib—MAP2K5—MAPK Signaling Pathway—CASP7—vitiligo	0.000458	0.00692	CbGpPWpGaD
Erlotinib—CYP1A1—Oxidative Stress—CAT—vitiligo	0.000446	0.00673	CbGpPWpGaD
Erlotinib—ABCB1—thyroid gland—vitiligo	0.000443	0.0075	CbGeAlD
Erlotinib—JAK3—Immune System—LRR1—vitiligo	0.000406	0.00613	CbGpPWpGaD
Erlotinib—CYP1A2—Estrogen metabolism—GSTM1—vitiligo	0.000404	0.0061	CbGpPWpGaD
Erlotinib—MKNK1—Signaling by FGFR—CD80—vitiligo	0.00039	0.00589	CbGpPWpGaD
Erlotinib—ABL1—Factors involved in megakaryocyte development and platelet production—SH2B3—vitiligo	0.000374	0.00565	CbGpPWpGaD
Erlotinib—MKNK1—Signaling by FGFR in disease—CD80—vitiligo	0.000363	0.00548	CbGpPWpGaD
Erlotinib—EGFR—SHP2 signaling—IL2RA—vitiligo	0.00035	0.00529	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—CD44—vitiligo	0.000333	0.00502	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—DDX6—vitiligo	0.000329	0.00497	CbGpPWpGaD
Erlotinib—JAK3—Immune System—NLRP1—vitiligo	0.000325	0.0049	CbGpPWpGaD
Erlotinib—CYP1A1—Tryptophan metabolism—CAT—vitiligo	0.000317	0.00478	CbGpPWpGaD
Erlotinib—CYP3A4—Estrogen metabolism—GSTM1—vitiligo	0.000312	0.00471	CbGpPWpGaD
Erlotinib—EGFR—Signaling by SCF-KIT—SH2B3—vitiligo	0.000311	0.00469	CbGpPWpGaD
Erlotinib—UGT1A1—Phase II conjugation—GSTM1—vitiligo	0.00031	0.00468	CbGpPWpGaD
Erlotinib—JAK3—Immune System—HERC2—vitiligo	0.000308	0.00465	CbGpPWpGaD
Erlotinib—ABL1—DNA Damage Response (only ATM dependent)—CAT—vitiligo	0.000294	0.00444	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—LRR1—vitiligo	0.000293	0.00442	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—NLRP1—vitiligo	0.000285	0.00431	CbGpPWpGaD
Erlotinib—UGT1A1—Biological oxidations—GSTT1—vitiligo	0.000285	0.0043	CbGpPWpGaD
Erlotinib—JAK3—Platelet activation, signaling and aggregation—IL2RA—vitiligo	0.000275	0.00415	CbGpPWpGaD
Erlotinib—CYP1B1—Biological oxidations—GSTT1—vitiligo	0.000265	0.00401	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	0.00026	0.00392	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—SH2B3—vitiligo	0.000256	0.00386	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—GZMB—vitiligo	0.000248	0.00374	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—CASP7—vitiligo	0.000246	0.00371	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—NLRP1—vitiligo	0.000244	0.00368	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—MC1R—vitiligo	0.000228	0.00344	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—IL2RA—vitiligo	0.000227	0.00343	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—CASP7—vitiligo	0.000227	0.00343	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—HERC2—vitiligo	0.000222	0.00335	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	0.000222	0.00335	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—CAT—vitiligo	0.000216	0.00327	CbGpPWpGaD
Erlotinib—EGFR—Constitutive PI3K/AKT Signaling in Cancer—CD80—vitiligo	0.000213	0.00322	CbGpPWpGaD
Erlotinib—ABL1—Immune System—LRR1—vitiligo	0.000208	0.00314	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—CD44—vitiligo	0.000207	0.00313	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—MC1R—vitiligo	0.000207	0.00313	CbGpPWpGaD
Erlotinib—UGT1A1—NRF2 pathway—GSTM1—vitiligo	0.000207	0.00312	CbGpPWpGaD
Erlotinib—CYP1A2—Tryptophan metabolism—CAT—vitiligo	0.000202	0.00305	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—CTLA4—vitiligo	0.000199	0.00301	CbGpPWpGaD
Erlotinib—MAP2K5—NGF signalling via TRKA from the plasma membrane—CD80—vitiligo	0.000198	0.00299	CbGpPWpGaD
Erlotinib—EGFR—PI-3K cascade—CD80—vitiligo	0.000192	0.0029	CbGpPWpGaD
Erlotinib—EGFR—PI3K/AKT activation—CD80—vitiligo	0.000188	0.00283	CbGpPWpGaD
Erlotinib—EGFR—GAB1 signalosome—CD80—vitiligo	0.000186	0.00281	CbGpPWpGaD
Erlotinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—CD80—vitiligo	0.000182	0.00275	CbGpPWpGaD
Erlotinib—UGT1A1—Biological oxidations—GSTM1—vitiligo	0.000181	0.00274	CbGpPWpGaD
Erlotinib—UGT1A1—Metapathway biotransformation—GSTM1—vitiligo	0.000179	0.0027	CbGpPWpGaD
Erlotinib—CYP1A2—Phase II conjugation—GSTT1—vitiligo	0.000178	0.00269	CbGpPWpGaD
Erlotinib—EGFR—Immune System—LRR1—vitiligo	0.000178	0.00268	CbGpPWpGaD
Erlotinib—CYP3A5—Biological oxidations—GSTT1—vitiligo	0.000173	0.00261	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—CAT—vitiligo	0.000172	0.00259	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—CCR6—vitiligo	0.00017	0.00257	CbGpPWpGaD
Erlotinib—CYP1B1—Biological oxidations—GSTM1—vitiligo	0.000169	0.00255	CbGpPWpGaD
Erlotinib—CYP1B1—Metapathway biotransformation—GSTM1—vitiligo	0.000167	0.00252	CbGpPWpGaD
Erlotinib—ABL1—Immune System—NLRP1—vitiligo	0.000166	0.00251	CbGpPWpGaD
Erlotinib—CYP1A1—Biological oxidations—GSTT1—vitiligo	0.000163	0.00247	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—MC1R—vitiligo	0.000162	0.00245	CbGpPWpGaD
Erlotinib—ABL1—Immune System—HERC2—vitiligo	0.000158	0.00238	CbGpPWpGaD
Erlotinib—CYP3A4—Tryptophan metabolism—CAT—vitiligo	0.000156	0.00235	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CCR6—vitiligo	0.000155	0.00234	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling by NGF—CD80—vitiligo	0.000152	0.0023	CbGpPWpGaD
Erlotinib—CYP2C8—Biological oxidations—GSTT1—vitiligo	0.00015	0.00226	CbGpPWpGaD
Erlotinib—EGFR—Signaling by SCF-KIT—CD80—vitiligo	0.000144	0.00217	CbGpPWpGaD
Erlotinib—EGFR—Immune System—NLRP1—vitiligo	0.000142	0.00214	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—IL2RA—vitiligo	0.000142	0.00214	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IFIH1—vitiligo	0.000141	0.00213	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CCR6—vitiligo	0.000141	0.00213	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—IL2RA—vitiligo	0.000138	0.00209	CbGpPWpGaD
Erlotinib—EGFR—Downstream signaling of activated FGFR—CD80—vitiligo	0.000137	0.00208	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB4—CD80—vitiligo	0.000135	0.00204	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HERC2—vitiligo	0.000135	0.00203	CbGpPWpGaD
Erlotinib—MKNK1—Disease—CD44—vitiligo	0.000133	0.00201	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—SH2B3—vitiligo	0.000131	0.00198	CbGpPWpGaD
Erlotinib—EGFR—Downstream signal transduction—CD80—vitiligo	0.000129	0.00195	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR—CD80—vitiligo	0.000129	0.00194	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB2—CD80—vitiligo	0.000128	0.00193	CbGpPWpGaD
Erlotinib—EGFR—DAP12 signaling—CD80—vitiligo	0.000127	0.00192	CbGpPWpGaD
Erlotinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—CD80—vitiligo	0.000126	0.00189	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CCR6—vitiligo	0.000124	0.00188	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—IFIH1—vitiligo	0.000124	0.00188	CbGpPWpGaD
Erlotinib—CYP2D6—Biological oxidations—GSTT1—vitiligo	0.000123	0.00186	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MC1R—vitiligo	0.000122	0.00185	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CCR6—vitiligo	0.000121	0.00183	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR in disease—CD80—vitiligo	0.00012	0.00181	CbGpPWpGaD
Erlotinib—EGFR—DAP12 interactions—CD80—vitiligo	0.00012	0.00181	CbGpPWpGaD
Erlotinib—EGFR—Fc epsilon receptor (FCERI) signaling—CD80—vitiligo	0.00012	0.00181	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR—CD80—vitiligo	0.000119	0.00179	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR in Cancer—CD80—vitiligo	0.000118	0.00178	CbGpPWpGaD
Erlotinib—EGFR—Signaling by PDGF—CD80—vitiligo	0.000117	0.00177	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—CD80—vitiligo	0.000115	0.00174	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—SH2B3—vitiligo	0.000115	0.00173	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—GZMB—vitiligo	0.000114	0.00172	CbGpPWpGaD
Erlotinib—CYP1A2—Phase II conjugation—GSTM1—vitiligo	0.000113	0.00171	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	0.000112	0.00169	CbGpPWpGaD
Erlotinib—EGFR—B Cell Activation—CD80—vitiligo	0.000111	0.00167	CbGpPWpGaD
Erlotinib—CYP3A5—Biological oxidations—GSTM1—vitiligo	0.00011	0.00166	CbGpPWpGaD
Erlotinib—CYP3A5—Metapathway biotransformation—GSTM1—vitiligo	0.000109	0.00164	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CD44—vitiligo	0.000109	0.00164	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CTLA4—vitiligo	0.000107	0.00162	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—IFIH1—vitiligo	0.000106	0.0016	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CCR6—vitiligo	0.000106	0.0016	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—CD44—vitiligo	0.000106	0.0016	CbGpPWpGaD
Erlotinib—EGFR—NGF signalling via TRKA from the plasma membrane—CD80—vitiligo	0.000106	0.0016	CbGpPWpGaD
Erlotinib—CYP1A2—Biological oxidations—GSTT1—vitiligo	0.000104	0.00157	CbGpPWpGaD
Erlotinib—CYP1A1—Biological oxidations—GSTM1—vitiligo	0.000104	0.00157	CbGpPWpGaD
Erlotinib—CYP1A1—Metapathway biotransformation—GSTM1—vitiligo	0.000103	0.00155	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MC1R—vitiligo	9.98e-05	0.00151	CbGpPWpGaD
Erlotinib—CYP2C8—Biological oxidations—GSTM1—vitiligo	9.55e-05	0.00144	CbGpPWpGaD
Erlotinib—CYP2C8—Metapathway biotransformation—GSTM1—vitiligo	9.42e-05	0.00142	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CCR6—vitiligo	9.14e-05	0.00138	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—MC1R—vitiligo	9.06e-05	0.00137	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—IL2RA—vitiligo	8.95e-05	0.00135	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—SH2B3—vitiligo	8.66e-05	0.00131	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—GZMB—vitiligo	8.61e-05	0.0013	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CD8A—vitiligo	8.24e-05	0.00124	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—CD80—vitiligo	8.16e-05	0.00123	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—IL2RA—vitiligo	8.13e-05	0.00123	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—GSTT1—vitiligo	8.04e-05	0.00121	CbGpPWpGaD
Erlotinib—CYP2D6—Biological oxidations—GSTM1—vitiligo	7.84e-05	0.00118	CbGpPWpGaD
Erlotinib—CYP2D6—Metapathway biotransformation—GSTM1—vitiligo	7.73e-05	0.00117	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CTLA4—vitiligo	7.73e-05	0.00117	CbGpPWpGaD
Erlotinib—MKNK1—Disease—CD80—vitiligo	7.59e-05	0.00115	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CCR6—vitiligo	7.45e-05	0.00112	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL2RA—vitiligo	7.43e-05	0.00112	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—IL2RA—vitiligo	7.25e-05	0.00109	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CCR6—vitiligo	7.24e-05	0.00109	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IFIH1—vitiligo	7.24e-05	0.00109	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—SH2B3—vitiligo	7.06e-05	0.00107	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—GZMB—vitiligo	7.02e-05	0.00106	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—IL2RA—vitiligo	6.92e-05	0.00105	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CCR6—vitiligo	6.77e-05	0.00102	CbGpPWpGaD
Erlotinib—CYP1A2—Biological oxidations—GSTM1—vitiligo	6.64e-05	0.001	CbGpPWpGaD
Erlotinib—CYP1A2—Metapathway biotransformation—GSTM1—vitiligo	6.55e-05	0.000989	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—SH2B3—vitiligo	6.44e-05	0.000972	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL2RA—vitiligo	6.37e-05	0.000961	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CD80—vitiligo	6.2e-05	0.000936	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IFIH1—vitiligo	6.18e-05	0.000934	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CCR6—vitiligo	6.18e-05	0.000934	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD8A—vitiligo	5.94e-05	0.000897	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD44—vitiligo	5.56e-05	0.00084	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CTLA4—vitiligo	5.48e-05	0.000828	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CD80—vitiligo	5.45e-05	0.000822	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MC1R—vitiligo	5.35e-05	0.000808	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CD80—vitiligo	5.31e-05	0.000802	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—CD44—vitiligo	5.22e-05	0.000789	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—GSTM1—vitiligo	5.12e-05	0.000774	CbGpPWpGaD
Erlotinib—CYP3A4—Metapathway biotransformation—GSTM1—vitiligo	5.05e-05	0.000763	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—GSTT1—vitiligo	4.87e-05	0.000735	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL2RA—vitiligo	4.8e-05	0.000725	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD44—vitiligo	4.76e-05	0.000718	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CTLA4—vitiligo	4.69e-05	0.000708	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CD80—vitiligo	4.65e-05	0.000703	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—GSTT1—vitiligo	4.54e-05	0.000685	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD80—vitiligo	4.47e-05	0.000675	CbGpPWpGaD
Erlotinib—EGFR—Disease—CD44—vitiligo	4.39e-05	0.000663	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD8A—vitiligo	4.22e-05	0.000637	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GSTT1—vitiligo	4.13e-05	0.000624	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CD44—vitiligo	4.05e-05	0.000611	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CD80—vitiligo	4.01e-05	0.000605	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCR6—vitiligo	4e-05	0.000604	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL2RA—vitiligo	3.91e-05	0.000591	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL2RA—vitiligo	3.8e-05	0.000574	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SH2B3—vitiligo	3.79e-05	0.000572	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CD44—vitiligo	3.77e-05	0.00057	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—GZMB—vitiligo	3.77e-05	0.000569	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD8A—vitiligo	3.6e-05	0.000544	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—IL2RA—vitiligo	3.57e-05	0.000539	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL2RA—vitiligo	3.56e-05	0.000537	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CD44—vitiligo	3.43e-05	0.000518	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CAT—vitiligo	3.28e-05	0.000496	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CD80—vitiligo	3.27e-05	0.000493	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL2RA—vitiligo	3.25e-05	0.00049	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD80—vitiligo	3.17e-05	0.000479	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—GSTM1—vitiligo	3.1e-05	0.000468	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CAT—vitiligo	3.06e-05	0.000462	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GSTT1—vitiligo	2.96e-05	0.000447	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—GSTM1—vitiligo	2.89e-05	0.000437	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GSTT1—vitiligo	2.8e-05	0.000422	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CAT—vitiligo	2.79e-05	0.000421	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD80—vitiligo	2.71e-05	0.000409	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GSTM1—vitiligo	2.63e-05	0.000397	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GSTT1—vitiligo	2.56e-05	0.000387	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GSTT1—vitiligo	2.55e-05	0.000385	CbGpPWpGaD
Erlotinib—EGFR—Disease—CD80—vitiligo	2.5e-05	0.000378	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CD44—vitiligo	2.46e-05	0.000371	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CD44—vitiligo	2.32e-05	0.000351	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GSTT1—vitiligo	2.23e-05	0.000337	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CD44—vitiligo	2.13e-05	0.000322	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CD44—vitiligo	2.12e-05	0.00032	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GSTT1—vitiligo	2.1e-05	0.000318	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL2RA—vitiligo	2.1e-05	0.000317	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CAT—vitiligo	2e-05	0.000301	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CAT—vitiligo	1.89e-05	0.000285	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GSTM1—vitiligo	1.88e-05	0.000285	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CD44—vitiligo	1.86e-05	0.00028	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GSTT1—vitiligo	1.78e-05	0.000269	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GSTM1—vitiligo	1.78e-05	0.000269	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CD80—vitiligo	1.75e-05	0.000265	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CD44—vitiligo	1.75e-05	0.000264	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CAT—vitiligo	1.73e-05	0.000261	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CAT—vitiligo	1.72e-05	0.00026	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GSTM1—vitiligo	1.63e-05	0.000246	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GSTM1—vitiligo	1.62e-05	0.000245	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CAT—vitiligo	1.51e-05	0.000227	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CD44—vitiligo	1.48e-05	0.000224	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GSTM1—vitiligo	1.42e-05	0.000215	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CAT—vitiligo	1.42e-05	0.000214	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GSTT1—vitiligo	1.38e-05	0.000208	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GSTM1—vitiligo	1.34e-05	0.000202	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CAT—vitiligo	1.2e-05	0.000182	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CD44—vitiligo	1.14e-05	0.000173	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GSTM1—vitiligo	1.14e-05	0.000171	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CAT—vitiligo	9.28e-06	0.00014	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GSTM1—vitiligo	8.76e-06	0.000132	CbGpPWpGaD
